Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 among heart transplant recipients in Germany: a multicenter survey.
Rivinius R, Kaya Z, Schramm R, Boeken U, Provaznik Z, Heim C, Knosalla C, Schoenrath F, Rieth A, Berchtold-Herz M, Barten MJ, Rauschning D, Mücke VT, Heyl S, Pistulli R, Grinninger C, Hagl C, Gummert JF, Warnecke G, Schulze PC, Katus HA, Kreusser MM, Raake PW. Rivinius R, et al. Among authors: grinninger c. Clin Res Cardiol. 2020 Dec;109(12):1531-1539. doi: 10.1007/s00392-020-01722-w. Epub 2020 Aug 11. Clin Res Cardiol. 2020. PMID: 32783099 Free PMC article.
Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
Kaczmarek I, Zaruba MM, Beiras-Fernandez A, Reimann R, Nickel T, Grinninger C, Sadoni S, Hagl C, Meiser B. Kaczmarek I, et al. Among authors: grinninger c. J Heart Lung Transplant. 2013 Mar;32(3):277-84. doi: 10.1016/j.healun.2012.11.028. J Heart Lung Transplant. 2013. PMID: 23415313 Clinical Trial.
De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
Guethoff S, Stroeh K, Grinninger C, Koenig MA, Kleinert EC, Rieger A, Mayr T, von Ziegler F, Reichart B, Hagl C, Schramm R, Kaczmarek I, Meiser BM. Guethoff S, et al. Among authors: grinninger c. J Heart Lung Transplant. 2015 May;34(5):634-42. doi: 10.1016/j.healun.2014.11.025. Epub 2014 Dec 9. J Heart Lung Transplant. 2015. PMID: 25701373 Clinical Trial.
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation.
Deuse T, Bara C, Barten MJ, Hirt SW, Doesch AO, Knosalla C, Grinninger C, Stypmann J, Garbade J, Wimmer P, May C, Porstner M, Schulz U. Deuse T, et al. Among authors: grinninger c. Contemp Clin Trials. 2015 Nov;45(Pt B):356-363. doi: 10.1016/j.cct.2015.09.009. Epub 2015 Sep 9. Contemp Clin Trials. 2015. PMID: 26363128 Clinical Trial.
Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study.
Barten MJ, Hirt SW, Garbade J, Bara C, Doesch AO, Knosalla C, Grinninger C, Stypmann J, Sieder C, Lehmkuhl HB, Porstner M, Schulz U. Barten MJ, et al. Among authors: grinninger c. Am J Transplant. 2019 Mar 18. doi: 10.1111/ajt.15361. Online ahead of print. Am J Transplant. 2019. PMID: 30884079 Free article.
Hemodynamic markers of pulmonary vasculopathy for prediction of early right heart failure and mortality after heart transplantation.
Rieth AJ, Rivinius R, Lühring T, Grün D, Keller T, Grinninger C, Schüttler D, Bara CL, Helmschrott M, Frey N, Sandhaus T, Schulze C, Kriechbaum S, Vietheer J, Sindermann J, Welp H, Lichtenberg A, Choi YH, Richter M, Tello K, Richter MJ, Hamm CW, Boeken U. Rieth AJ, et al. Among authors: grinninger c. J Heart Lung Transplant. 2023 Apr;42(4):512-521. doi: 10.1016/j.healun.2022.10.002. Epub 2022 Oct 9. J Heart Lung Transplant. 2023. PMID: 36333208
16 results